In Clinical Conditions of LRTI Provide Great Performance
Levofloxacin 500 / 250 mg. Tablets
- Broad-spectrum antibacterial agent
- active againt a range of gram-positive, gram-negative atypicals and anaerobes
- Provides clinical and bacteriological efficacy in a range of infections
Leaf Provides advantage of once daily administration
Among all fluoroquinolones , levofloxacin shows grearest activity against the Mycobaterium tuberculosis
- Respiratory tract infections
- Nosicomial Pneumonia
- Community acquired pneumonia
- acute exacerbations of chronic bronchitis
- urinary tract infections
- skin & skin structure infections